Protective effects of vescalagin from Pink wax apple [ Syzygium samarangense (Blume) Merrill and Perry] fruit against methylglyoxal-induced inflammation and carbohydrate metabolic disorder in rats

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 29, 2013, Pages 7102-7109

  Chang, Wen Chang ^a   Shen, Szu Chuan ^b   Wu, James Swi Bea ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

antiglycation; carbohydrate metabolic disorder; inflammation; methylglyoxal; vescalagin

Indexed keywords

ANTIGLYCATION; INFLAMMATION; METABOLIC DISORDERS; METHYLGLYOXAL; VESCALAGIN;

CARBOHYDRATES; PATHOLOGY; RATS;

METABOLISM;

C PEPTIDE; CHOLESTEROL; INSULIN; INTERLEUKIN 6; METHYLGLYOXAL; PROTECTIVE AGENT; TANNIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VESCALAGIN;

ANIMAL; ARTICLE; BLOOD; CARBOHYDRATE METABOLISM; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; EUGENIA; FRUIT; GLUCOSE TOLERANCE TEST; INFLAMMATION; MALE; METABOLIC DISORDER; METABOLISM; ORGAN SIZE; RAT; WISTAR RAT;

ANIMALS; C-PEPTIDE; CARBOHYDRATE METABOLISM; CHOLESTEROL; EUGENIA; FRUIT; GLUCOSE TOLERANCE TEST; HYDROLYZABLE TANNINS; INFLAMMATION; INSULIN; INTERLEUKIN-6; MALE; METABOLIC DISEASES; ORGAN SIZE; PROTECTIVE AGENTS; PYRUVALDEHYDE; RATS; RATS, WISTAR; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880824709     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf4020284     Document Type: Article

References (41)

1. WHO, (2012; http://www.who.int/diabetes/en/index.html.
2. Rabbani, N.; Thornalley, P. J. Glyoxalase in diabetes, obesity and related disorders Semin. Cell Dev. Biol. 2011, 22, 309-317
3. Lin, S.; Yang, Z.; Liu, H.; Tang, L.; Cai, Z. Beyond glucose: metabolic shifts in responses to the effects of oral glucose tolerance test and the high-fructose diet in rats Mol. BioSyst. 2011, 7, 1537-1548
4. Gensberger, S.; Mittelmaier, S.; Glomb, M. A.; Pischetsrieder, M. Identification and quantification of six major α-dicarbonyl process contaminants in high-fructose corn syrup Anal. Bioanal. Chem. 2012, 403 (10) 2923-2931
5. Desai, K. M.; Chang, T.; Wang, H.; Banigesh, A.; Dhar, A.; Liu, J.; Untereiner, A.; Wu, L. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can. J. Physiol. Pharmacol. 2010, 88, 273-284
6. Lee, B. H.; Hsu, W. H.; Huang, T.; Chang, Y. Y.; Hsu, Y. W.; Pan, T. M. Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated Wistar rats J. Agric. Food Chem. 2013, 61 (6) 1288-1298
7. Matafome, P.; Sena, C.; Seiça, R. Methylglyoxal, obesity, and diabetes Endocrine 2013, 43 (3) 472-484
8. Dhar, A.; Dhar, I.; Jiang, B.; Desai, K. M.; Wu, L. Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats Diabetes 2011, 60, 899-908
9. Arrbias-Lorenzo, G.; Morales, F. J. Analysis, distribution, and dietary exposure of glyoxal and methylglyoxal in cookies and their relationship with other heat-induced contaminants J. Agric. Food Chem. 2010, 58, 2966-2972
10. Uribarri, J.; Woodruff, S.; Goodman, S.; Cai, W.; Chen, X.; Pyzik, R.; Yong, A.; Striker, G. E.; Vlassara, H. Advanced glycation end products in foods and a practical guide to their reduction in the diet J. Am. Diet Assoc. 2010, 110 (6) 911-916
11. Wang, J.; Chang, T. Methylglyoxal content in drinking coffee as a cytotoxic factor J. Food Sci. 2010, 75, H167-H171
12. Falone, S.; D'Alessandro, A.; Mirabilio, A.; Petruccelli, G.; Cacchio, M.; Di Ilio, C.; Di Loreto, S.; Amicarelli, F. Long term running biphasically improves methylglyoxal-related metabolism, redox homeostasis and neurotrophic support within adult mouse brain cortex PLoS One 2012, 7 (2) e31401
13. Kim, J.; Kim, O.; Kim, C.; Sohn, E.; Jo, K.; Kim, J. Accumulation of argpyrimidine, a methylglyoxal-derived advanced glycation end product, increases apoptosis of lens epithelial cells both in vitro and in vivo Exp. Mol. Med. 2012, 44 (2) 167-175
14. Kumagai, T.; Nangaku, M.; Kojima, I.; Nagai, R.; Ingelfinger, J.; Miyata, T.; Fujita, T.; Inagi, R. Glyoxalase I overexpression ameliorates renal ischemic-reperfusion injury in rats Am. J. Physiol. Renal Physiol. 2009, 296, F912-F921
15. Goldin, A.; Beckman, J.; Schmidt, A.; Creager, M. Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 2006, 114, 597-605
16. Park, C. H.; Tanaka, T.; Kim, H. Y.; Park, J. C.; Yokozawa, T. Protective effects of Corni Fructus against advanced glycation endproducts and radical scavenging eCAM 2012, 1-7
17. Heber, D. Multitargeted therapy of cancer by ellagitannins Cancer Lett. 2008, 269, 262-268
18. Fridrich, D.; Glabasnia, A.; Fritz, J.; Esselen, M.; Pahlke, G.; Hofmann, T.; Marko, D. Oak ellagitannins suppress the phosphorylation of the epidermal growth factor receptor in human colon carcinoma cells J. Agric. Food Chem. 2008, 56, 3010-3015
19. Shen, S. C.; Chang, W. C. Hypotriglyceridemic and hypoglycemic effects of vescalagin from Pink wax apple [ Syzygium samarangense (Blume) Merrill and Perry cv. Pink] in high-fructose diet-induced diabetic rats Food Chem. 2013, 136, 858-863
20. Chang, W. C.; Shen, S. C. Effect of water extracts from edible Myrtaceae plants on uptake of 2-(N -(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2- deoxyglucose (2-NBDG) in tumor necrosis factor-α-treated FL83B mouse hepatocytes Phytother. Res. 2013, 27, 236-243
21. Yildiz, G.; Demiryürek, A. T.; Sahin-Erdemli, I.; Kanzik, I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence Br. J. Pharmacol. 1998, 124 (5) 905-910
22. Ahmed, N.; Thornalley, P. J. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 2007, 9, 233-245
23. Guo, Q.; Mori, T.; Jiang, Y.; Hu, C.; Osaki, Y.; Yoneki, Y.; Sun, Y.; Hosoya, T.; Kawamata, A.; Ogawa, S.; Nakayama, M.; Miyata, T.; Ito, S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats J. Hypertens. 2009, 27 (8) 1664-1671
24. Singh, I.; Singh, P. K.; Bhansali, S.; Shafiq, N.; Malhotra, S.; Pandhi, P.; Singh, A. P. Effects of three different doses of a fruit extract of Terminalia chebula on metabolic components of metabolic syndrome, in a rat model Phytother. Res. 2010, 24, 107-112
25. Diaz-Delfin, J.; Morales, M.; Caelles, C. Hypoglycemic action of thiazolidine-diones/peroxisome proliferator-activated receptor-γ by inhibition of the c-Jun NH2-terminal kinase pathway Diabetes 2007, 56, 1865-1871
26. Hirai, S.; Takahashi, N.; Tsuyosh Ackerman, W. E.; Zhang, X. L.; Rovin, B. H.; Kniss, D. A. Modulation of cytokine-induced cyclooxygenase2 expression by PPAR-γ ligands through NFκB signal disruption in human WISH and amnion cells Biol. Reprod. 2005, 73, 527-535
27. Yamada, T.; Kuno, A.; Masuda, K.; Ogawa, K.; Sogawa, M.; Nakamura, S.; Ando, T.; Sano, H.; Nakazawa, T.; Ohara, H.; Nomura, T.; Joh, T.; Itoh, M. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats J. Pharmacol. Exp. Ther. 2003, 307 (1) 17-23
28. Chao, J.; Li, H. J.; Yao, Y. Y.; Shen, B.; Gao, L.; Bledsoe, G.; Chao, L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity Hypertension 2007, 49 (3) 490-497
29. Sureshkumar, S. V.; Mishra, S. H. Hepatoprotective effect of extracts from Pergularia daemia Forsk J. Ethnopharmacol. 2006, 107, 164-168
30. 4-induced hepatotoxicity in rodents Fitoterapia 2002, 73, 557-563
31. Dong, Q.; Yang, K.; Wong, S. M.; O'Brien, P. J. Hepatocyte or serum albumin protein carbonylation by oxidized fructose metabolites: Glyceraldehyde or glycolaldehyde as endogenous toxins? Chem.-Biol. Interact. 2010, 188, 31-37
32. Ginsberg, H. N. Insulin resistance and cardiovascular disease J. Clin. Invest. 2000, 106, 453-458
33. Desai, K.; Wu, L. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons? Recent Pat. Cardiovasc. Drug Discov. 2007, 2 (2) 89-99
34. Mukohda, M.; Okada, M.; Hara, Y.; Yamawaki, H. Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility J. Pharmacol. Sci. 2012, 118 (3) 303-310
35. Thornalley, P. J. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation Biochem. Soc. Trans. 2003, 31, 1343-1348
36. Panchal, S. K.; Brown, L. Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats Eur. J. Nutr. 2013, 52, 397-408
37. Fiory, F.; Lombardi, A.; Miele, C.; Giudicelli, J.; Beguinot, F.; Van Obberghen, E. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E Diabetologia 2011, 54 (11) 2941-2952
38. Hotamisligil, G. S. Inflammatory pathways and insulin action Int. J. Obes. Relat. Metab. Disord. 2003, 27 (Suppl. 3) S53-S55
39. Peraldi, P.; Xu, M.; Spiegelman, B. M. Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin singaling J. Clin. Invest. 1996, 100, 1863-1869
40. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease Diabetes Metab. Rev. 1988, 4, 437-451
41. Thornalley, P. J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Arch. Biochem. Biophys. 2003, 419, 31-40